Article info

Download PDFPDF

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
  1. Professor P P Tak, Division of Clinical Immunology and Rheumatology, F4-218, Academic Medical Center/University of Amsterdam, Meibergdreef 9 1105 AZ Amsterdam, The Netherlands; P.P.Tak{at}amc.uva.nl
View Full Text

Citation

Wijbrandts CA, Dijkgraaf MGW, Kraan MC, et al
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium

Publication history

  • Accepted November 18, 2007
  • First published November 29, 2007.
Online issue publication 
July 11, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.